| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |